Literature DB >> 14569268

Spinal subarachnoid hematoma compressing the conus medullaris and associated with neurofibromatosis type 2.

T Inoue1, K Miyamoto, Y Kushima, H Kodama, H Nishibori, H Hosoe, K Shimizu.   

Abstract

STUDY
DESIGN: Report of a case of subarachnoid hematoma associated with neurofibromatosis type 2 (NF2) in a 10-year-old girl.
OBJECTIVE: To report a rare case of subarachnoid spontaneous hematoma associated with NF2, with no evidence of trauma.
SETTING: Gifu, Japan.
METHODS: The patient presented with severe leg pain. MRI revealed a subarachnoid hematoma at the level of L2 and a spinal cord tumor at the level of T6. The subarachnoid hematoma had low and high heterogeneous signal intensity on the T1-weighted image and low signal intensity on the T2-weighted image, indicating the presence of extracellular methemoglobin. The tumor and hematoma were resected.
RESULTS: Pathological analysis demonstrated that the surgical specimen removed from the area of L2 was a hematoma and the specimen from T6 was a neurinoma. At follow-up 1 year after surgery, the girl remained neurologically asymptomatic.
CONCLUSIONS: This rare case of spinal subarachnoid hematoma was associated with NF2. MRI was useful in establishing the diagnosis.

Entities:  

Mesh:

Year:  2003        PMID: 14569268     DOI: 10.1038/sj.sc.3101496

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  2 in total

1.  Intralesional and subarachnoid bleeding of a spinal schwannoma presenting with acute cauda equina syndrome.

Authors:  Mauro Dobran; Davide Nasi; Martina Della Costanza; Francesco Formica
Journal:  BMJ Case Rep       Date:  2019-07-12

2.  Subarachnoid hematoma of the craniocervical junction and upper cervical spine after traumatic cerebral contusion: case report.

Authors:  Alessandro Di Rienzo; Maurizio Iacoangeli; Lorenzo Alvaro; Roberto Colasanti; Elisa Moriconi; Maurizio Gladi; Niccolò Nocchi; Massimo Scerrati
Journal:  Neurol Med Chir (Tokyo)       Date:  2013       Impact factor: 1.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.